• 1
    Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002; 100: 19351947.
  • 2
    Ruggeri L, Mancusi A, Capanni M et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute mye-loid leukemia: challenging its predictive value. Blood 2007; 110: 433440.
  • 3
    Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 1977; 7: 655663.
  • 4
    Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002; 169: 51185129.
  • 5
    Mancusi A, Ruggeri L, McQueen K et al. Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation. Bone Marrow Transplant 2006; 37(1 Suppl): S3.
  • 6
    Chen C, Busson M, Rocha V et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant 2006; 38: 437444.
  • 7
    Cook M, Briggs D, Craddock C et al. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 2006; 107: 12301232.
  • 8
    Cooley S, Miller JS, Trachtenberg E et al. Activating KIR (B Haplotype) in unrelated donors improves disease-free survival after HLA-matched and mismatched allogeneic transplantation for acute myeloid leukemia: Implications for donor selection using KIR genotyping. ASH Ann Meet Abstr 2007; 110: 43.
  • 9
    Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 26012614.
  • 10
    Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411422.
  • 11
    Levey AS, Coresh J, Greene T et al. Using standard-ized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247254.
  • 12
    Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753763.
  • 13
    Vales-Gomez M, Reyburn HT, Erskine RA, Strominger J. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci U S A. 1998; 95: 1432614331.
  • 14
    Stewart CA, Laugier-Anfossi F, Vely F et al. Recogni-tion of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A. 2005; 102: 1322413229.
  • 15
    Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovi-rus by activating and inhibitory NK cell receptors. Science 2002; 296: 13231326.
  • 16
    Kreijveld E, Van Der Meer A, Tijssen HJ, Hilbrands LB, Joosten I. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation. Transplantation 2007; 84: 10451051.